Developmental problems and the child with special needs


Learning objectives

By the end of this chapter the reader should:

  • Be aware of the epidemiology of neurodisability

  • Know about the aetiology, different clinical patterns and management of cerebral palsy

  • Know about the causes of impaired development and regression

  • Know about attention deficit hyperactivity disorder (ADHD), autism spectrum disorders (ASD) and developmental coordination disorder (DCD)

Question 5.1

The epidemiology of disability

Which of the following statements BEST describes the epidemiology of disability in the UK? Select ONE answer only.

  • A.

    All children with a disability should be seen at a pupil referral unit

  • B.

    Around half of children with a disability have a Statement of Special Educational Needs, and around half of these attend a mainstream school

  • C.

    Disability typically affects 1–2% of the childhood population and most children in the UK with a disability attend a state-funded special school

  • D.

    Most children with a Statement of Special Educational Needs have either a physical disability or a sensory impairment

  • E.

    Nearly all children with a disability have a Statement of Special Educational Needs and attend a mainstream school

Answer 5.1

B. Around half of children with a disability have a Statement of Special Educational Needs, and around half of these children attend a mainstream school. See below for discussion.

Definition and numbers

In the UK, there are 770,000 children under the age of 16 years with a disability. This is about 1 child in 20. In January 2013, 229,390 children in England (2.8% of school-aged children) had a Statement of Special Educational Needs (SSEN), which is a legal document that sets out the special educational help which a child must receive by law. The document is issued by the local education authority (LEA) and is based on the needs, following assessment, of the individual child, drawn up from reports from health services (if applicable) and education. The percentage of children in receipt of an SSEN has remained unchanged for the past five years. Most children (53%) with an SSEN attend a mainstream education setting. Other settings include state-funded special schools (39.6%), independent schools (4.9%), non-maintained special schools (1.8%) and pupil referral units (0.7%).

The most common types of need for which children receive an SSEN are moderate or severe learning disability, speech, language and communication needs, behaviour, emotional and social difficulties, and autism spectrum disorders (ASD). The percentage of SSENs issued to children with a physical disability is around 6%, with children with sensory impairments making up another 5%.

At the end of 2014, a new system was launched in England for the assessment of a child's needs. This replaced the SSEN and is called the Education, Health and Care Plan (EHCP). The purpose of this multi-disciplinary assessment is to provide a more holistic view of a child's needs and includes assessments from health services, education and social care, as well as input from the family and child or young person themselves, before a document detailing a child's needs in each of these areas is drawn up. The new process is designed to be more rapid, with a target of completion in six months and to have more involvement of the family.

Causes of developmental problems

Early identification of children with severe or complex needs is required to ensure that early intervention programmes are initiated to offer support to parents and to ensure that a child's developmental potential is reached. A child with disordered development must be investigated rationally in line with a good clinical history and full physical examination, ensuring that a thorough assessment of the child's development in all areas is made. There are many potential causes of developmental problems in children, and these may be broadly classified as prenatal, perinatal, and postnatal ( Table 5.1 ).

Table 5.1
Potential causes of developmental impairment
Prenatal Perinatal Postnatal
Genetic
Single gene disorders (inherited or new mutation)
Chromosomal microduplications or deletions
Aneuploidy or tetraploidy
Preterm birth
55–60% of children born at 24–25 weeks' gestation have some degree of impairment, with around 15% having severe impairment (EPICure 2)
Infection
Meningoencephalitis (viral or bacterial)
Toxins
Alcohol (fetal alcohol spectrum disorder)
Smoking (intrauterine growth restriction)
Medication (e.g. valproate and spina bifida)
Recreational drugs (e.g. stimulants)
Infections
Bacterial (e.g. Group B streptococcal or other bacteria) or viral
Traumatic brain injury
Accidental or non-accidental
Drowning
Hanging/strangulation
Road traffic accidents
Conflict related (e.g. war-affected areas)
Infections
Congenital infection (e.g. toxoplasma, rubella, CMV, etc.)
Hypoxic-ischaemic encephalopathy Brain tumour
Direct effect or treatment
Other
Placental insufficiency and growth restriction
Intrauterine cerebral arterial or venous infarction
Congenital brain malformation (e.g. lissencephaly)
Physical
Traumatic brain injury
Inborn errors of metabolism
Impact on development often only after independent of placental support
Note: 75–80% of cases of cerebral palsy are due to antenatal events rather than injury occurring around the time of birth Environmental
Inadequate nutrition
Psychosocial adversity

A great deal of information can be gained from observing the child playing in the clinic room, and it is sometimes of value to observe the child in other settings, such as nursery, school or in the child's home. Investigation to look for an underlying aetiology informs discussion with parents, identifies treatment opportunities, guides management, and can be helpful for future pregnancies.

The clinical manifestations of disordered development

This section will deal with different presentations of disordered development, subdivided into the broad developmental categories. In reality, however, impairment in one area of development often co-exists with developmental impairment in another area.

Gross motor development

Children who present predominantly with motor difficulties, and who have an underlying pathology, are usually hypotonic, hypertonic, or have a global learning disability which impairs their intellectual ability to acquire motor skills.

Upper motor neuron lesions

Question 5.2

Cerebral palsy

An 18-month-old child attends the child development centre for a thorough assessment with a suspected diagnosis of cerebral palsy. Which of the following clinical features would be most likely to suggest an alternative diagnosis? Select ONE answer only.

  • A.

    Dystonia

  • B.

    Family history of cerebral palsy

  • C.

    Hyperkinesia

  • D.

    Prematurity

  • E.

    Spasticity

Answer 5.2

B. Family history of cerebral palsy. The explanation is considered below.

Upper motor neuron lesions usually present with hypertonia. The most common disabling condition in children with hypertonia is cerebral palsy, particularly of the spastic and dystonic type, where there is loss of the usual balance of excitatory and inhibitory muscle control.

Cerebral palsy

Cerebral palsy is a descriptive term which has been defined as ‘a group of permanent disorders of movement and posture causing activity limitation that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cognition, communication and behaviour, by epilepsy, and by secondary musculoskeletal disorders’.

Children with cerebral palsy are not always hypertonic, but there are four main clinical types, some of which have well-described associations with underlying pathologies ( Table 5.2 ).

  • 1.

    Spasticity : This is a velocity-dependent increase in tonic stretch receptors. Assessment of spasticity must be dynamic and is often described as feeling like a ‘clasp knife’.

  • 2.

    Dystonia : This is spasm and sustained contraction of a muscle, leading to abnormal posturing. In time, it can lead to contractures. It is often described as feeling like ‘lead-pipe rigidity’.

  • 3.

    Ataxia : Uncoordinated movements linked to a disturbed sense of balance and depth perception.

  • 4.

    Choreo-athetoid : Hyperkinesia (excess of involuntary movements). These are often writhing in nature.

Table 5.2
Common patterns of cerebral palsy *
Pattern of cerebral palsy Area of brain commonly affected Potential causes
Unilateral spastic (~25%) Infarction within distribution of middle cerebral artery
(Left middle cerebral artery distribution more commonly affected than right)
  • Intrapartum asphyxia

  • Ischaemia (stroke) in late third trimester

  • Intraventricular haemorrhages (IVH) related to preterm birth

Bilateral spastic
(~55%, roughly equal proportions diplegia to quadriplegia)
Bilateral cerebral hemisphere infarction
Cerebral dysgenesis
  • Genetic

  • Infections in early pregnancy (CMV, toxoplasmosis)

  • Vascular accidents/malformations

  • Less commonly:

  • Neonatal meningitis or metabolic insult

  • Postnatal causes

Dyskinetic (~15%) Discrete gliotic lesions in the putamina and thalami
  • Acute profound asphyxia in late third trimester or intrapartum (e.g. cord prolapse, antepartum haemorrhage, uterine rupture)

  • Bilirubin encephalopathy (kernicterus)

Ataxic (~5%)
  • Abnormal development of cerebellum

  • Dysmorphic syndromes

  • Less commonly:

  • Postnatal infection or trauma

* Many patients have a mixed clinical picture, and hypotonic cerebral palsy is also recognized.

Children with cerebral palsy often have a mixed picture of movements, and this classification does not accurately describe how severely disabled the child is by their movement disorder. The Gross Motor Function Classification System (GMFCS) scale is useful as it describes the functional ability of a child's gross motor skills rather than focusing on the individual type of cerebral palsy.

Cerebral palsy can be mimicked by several other conditions and before making a firm diagnosis the differential diagnosis needs to be considered ( Table 5.3 ).

Table 5.3
Conditions that can mimic cerebral palsy
  • Spinal cord tumours

  • Channelopathies

  • Sandifer syndrome

  • MECP2 duplication

  • Congenital dopa-responsive disorders

  • Genetic spastic paraplegia

  • Some metabolic conditions (GLUT1 deficiency, glutaric aciduria type 1)

  • Ataxia telangiectasia

Particular care should be taken when there is a ‘family history’ of cerebral palsy to check that there is not an underlying inheritable cause. One must also ensure that a child who presents with ‘ataxic cerebral palsy’ does not have a treatable or definable underlying cause.

Question 5.3

Management of cerebral palsy

Regarding the management of cerebral palsy, which of the following statements are true (T) and which are false (F)?

  • A.

    Baclofen passes freely across the blood–brain barrier

  • B.

    Botulinum toxin has permanent effects

  • C.

    Dantrolene commonly causes sedation

  • D.

    Diazepam mainly acts upon GABA receptors within the muscle

  • E.

    Tizanidine acts centrally, mainly within the motor cortex, on alpha-2 receptors

Answer 5.3

All false (see below).

Management of cerebral palsy

Meeting the child and family's complex needs requires a multi-disciplinary team (see below). Here, we will describe some of the drugs and procedures which may be helpful.

Specific drug management of spasticity

Drugs used in the management of spasticity and their sites of action are shown in Figure 5.1 .

Fig. 5.1, Drugs and their sites of action in the management of spasticity.

Diazepam : Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter regulating neuronal excitability in the nervous system. It has a direct effect on muscle tone. Diazepam is a GABA agonist. Due to its central location of action, it relieves spasticity and muscle spasms, but it has additional effects of sedation and acts as an anxiolytic. Long-term use can create dependency, but short-term use can be helpful for painful spasms (for example, after surgery), or to break cycles of distress and increasing spasticity.

Baclofen : Baclofen is also a GABA agonist and inhibits neuronal transmission at a spinal level. Its main adverse effect is sedation, which often limits its use. Its passage into the CSF when given orally is poor and high doses are often needed. When used intrathecally, via a surgically implanted continuous-delivery pump, only a tiny fraction of the equivalent oral dose needs to be given. This allows greater efficacy with fewer adverse effects.

Tizanidine : Tizanidine is an alpha-2 adrenergic receptor agonist and acts at the spinal level to help relieve spasms. It is particularly useful in children who are severely disabled by cerebral palsy and in those with night-time spasms, as it commonly has a sedative effect.

Botulinum toxin A : Botulinum toxin A works by chemically denervating the muscle, allowing the muscle to relax and thus improving function and cosmesis in some cases. It works by cleaving synaptosomal-associated protein (SNAP-25), which is a cytoplasmic protein which aids in the process of attaching the synaptic vesicle to the pre-synaptic membrane. This then stops the release of acetylcholine at the synapse and blocks neurotransmission. The effects gradually wear off (over about 3–6 months) as the myelin sheath retracts and new terminals are made, which form contacts with the myocyte to resume neurotransmission.

Dantrolene : Dantrolene works on spasticity and spasms by affecting the calcium uptake into skeletal muscles and decreasing the free intracellular calcium concentration. Sedation is less of a problem with dantrolene than with the other drugs mentioned, but it should be used cautiously as it can cause hepatic dysfunction and blood dyscrasias.

Other treatment for spasticity

Selective dorsal rhizotomy (SDR) : There has been renewed interest in the use of selective dorsal rhizotomy to treat spasticity, particularly in the more mobile groups of children with cerebral palsy (GMFCS levels 2 to 3). This surgical procedure divides some of the lumbar sensory nerve roots, thus interrupting the sensory–motor reflex arc responsible for increased muscle tone. Pre-operative assessment must include bladder assessment due to the risk of affecting continence, and children and families must be counselled about the risks. The child's general level of gross motor function is unlikely to change significantly, but there may be improvements in quality of gait together with improved comfort and ability to tolerate splints and postural management programme.

Question 5.4

The hypotonic (floppy) infant

A male infant is born at term but develops unexpected respiratory distress in the first few hours of life. He is admitted to the neonatal intensive care unit and started on antibiotics. Upon examination, he is noted to be hypotonic.

From the following list of possible anatomical locations (A–I), pick the area predominantly affected by pathology in each of the conditions (1–4) listed below:

  • A.

    Anterior horn cell

  • B.

    Cortex

  • C.

    Cerebellum

  • D.

    Muscle

  • E.

    Neuromuscular junction

  • F.

    Peripheral nerves

  • G.

    Spinal cord

  • H.

    Spinothalamic tract

  • I.

    Unknown

  • 1.

    Spinal muscular atrophy

  • 2.

    Congenital myasthenia gravis

  • 3.

    Down's syndrome

  • 4.

    Congenital myotonic dystrophy

Answer 5.4

  • 1.

    A. Anterior horn cell

  • 2.

    E. Neuromuscular junction

  • 3.

    I. Unknown

  • 4.

    D. Muscle

See below for discussion.

Central hypotonia

It is helpful to make a clinical distinction between central hypotonia (affecting predominantly the head and trunk), generalized hypotonia and weakness (affecting all aspects), and peripheral hypotonia (affecting predominantly the limbs). Moderate to severe central hypotonia (other than in a few specific cases) tends to be identified in the neonatal period, where these babies may present with respiratory difficulties, feeding difficulties or as a ‘floppy baby’.

Investigations may include:

  • Microbiological tests (if presenting in neonatal period, to rule out sepsis)

  • Neuroimaging

  • Blood ammonia and lactate levels (inborn errors of metabolism)

  • Plasma and urine amino acids and urine organic acids (organic acidaemias)

  • Very long chain fatty acids (peroxisomal disorders)

  • Microarray-based comparative genomic hybridization (microarray-CGH)

Specific disorders to be considered include: aneuploidy (e.g. Down's syndrome), single gene disorders (e.g. Prader–Willi syndrome), metabolic disorders (e.g. peroxisomal disorders) and structural (e.g. structural brain malformations). We present these below as examples of how these different disorders may present.

Down's syndrome

Down's syndrome is caused by an additional copy of chromosome 21, either due to non-disjunction (most commonly), by a rearrangement of genetic material, called an unbalanced translocation, where extra genetic material associated with chromosome 21 is inherited, or by mosaicism (see Chapter 9 , Genetics).

Babies with Down's syndrome have typical dysmorphic features and are centrally hypotonic. They show delay in all of their developmental milestones and may have initial feeding difficulties. They may have associated congenital anomalies, including heart defects (present in up to 50% of infants). Children with Down's syndrome will have ongoing additional physical and learning needs throughout childhood and into adulthood.

Many newborn children with Down's syndrome have flaccid muscles and are described as ‘floppy’. In some children, this disappears as the child develops, but many remain in this ‘floppy’ state. There are a few follow-up studies of infants with Down's syndrome and it seems that this infantile floppiness does improve over time. There is a fairly widespread belief that the children remain with a degree of hypotonia and this state is often invoked as being responsible for much of their delay in motor milestones and impaired motor function.

However, this is controversial since there is no proper agreement as to either the exact cause or the definition of hypotonia and there is no consensus as to how to measure it. Some recent studies have shown that the hypotonia seen when children and adults with Down's syndrome are not moving (i.e. their tendency to have more ‘floppy’ muscles at rest) does not actually impair coordinated movement. The fact that the muscles are floppy at rest suggests there may be some peripheral component to the observed hypotonia.

Prader–Willi syndrome

Prader–Willi syndrome is caused by a deletion on the long arm of the paternally inherited chromosome (15q13) in 70% of cases, or due to maternal uni­parental disomy (25%). The remaining 5% are due to an imprinting defect, and only this form carries an increased risk for future pregnancy.

Prader–Willi syndrome should be considered in babies with feeding difficulties, those requiring nasogastric tube feeding, sticky saliva, extreme hypokinesia and a combination of central hypotonia and limb dystonia. Children with Prader–Willi syndrome also have distinctive facial characteristics and other dysmorphic features. Despite initial poor feeding, children with Prader–Willi syndrome begin to show increased appetite as they grow. This can lead to excessive eating (hyperphagia) and life-threatening obesity. They also have hypogonadism, causing immature development of sexual organs and delay in puberty. Learning disabilities can be severe. They tend to be particularly impaired in their emotional and social development.

Peroxisomal disorders

Peroxisomes are spherical organelles within cells containing important oxidative and other enzymes. Babies with peroxisomal disorders tend to present with extreme hypotonia of the neck in the context of general neonatal hypotonia.

Peroxisomal disorders can be divided into two categories:

  • ‘Global’ peroxisomal disorders, where few or no peroxisomes are generated or where there are single peroxisomal enzyme defects that induce a similar phenotype.

  • Adrenoleukodystrophy, which is an X-linked inherited condition, caused by a defect in the gene that codes for one of the ATP-binding transporters within the cell.

Measurement of very long chain fatty acids may detect some peroxisomal disorders, but there is no ‘metabolic screen’ which will detect all of them. Results must be correlated with clinical findings.

Particular clinical features which should be sought where a peroxisomal disorder is suspected in a hypotonic child include:

  • Neonatal seizures

  • Retinal blindness (Leber amaurosis)

  • Sensorineural deafness

  • Dysmorphic features of specific syndromes (e.g. Zellweger)

  • Hepatomegaly

  • Leukodystrophy

  • Neuronal migration defects

Suspicion of a peroxisomal disorder should be present where a school-age boy shows developmental regression in the context of previously normal development (although there may be a number of other causes for this) and in older girls with spastic paraplegia.

Brain malformations

This category is very broad. There are many structural malformations within the brain which can lead to abnormal tone. One needs to ensure that the malformation is not caused by a metabolic disorder, which may require specific management.

Neuromuscular disorders

Neuromuscular disorders are conditions that lead to the impairment of muscle function, either directly or indirectly. In terms of pathophysiology, there are four major sites of pathology to consider: anterior horn cells, peripheral nerves, neuromuscular junction and muscle.

Anterior horn cells

Nerve impulses generated in the anterior horn cells lead to activation of muscle fibres. Anterior horn cell disease usually leads to a specific pattern of weakness depending on the affected part. This is because medial cells innervate proximal muscles, whilst lateral cells innervate more distal muscle groups.

Disruption of anterior horn cells can lead to de­nervation, and the damaged alpha motor neurons produce spontaneous action potentials. These spikes cause the muscle fibres that are part of that neuron's motor unit to fire. This causes muscle twitches. We observe them as fasciculations. Reflexes are also lost.

As further degeneration occurs, only the remnants of the axon close to the muscle fibres remain. These individual axon fibres can also generate spontaneous action potentials; however, these will only cause individual muscle fibres to contract, resulting in fibrill­ation on electrophysiological testing (rarely performed nowadays).

Spinal muscular atrophy

This is an autosomal recessive genetic condition caused by a defect in the SMN1 gene on chromosome 5, which encodes the SMN protein. SMN is necessary for the survival of motor neurons and where there is a deficit of this protein, death of neuronal cells in the anterior horn of the spinal cord occurs. The muscles with the largest number of motor neurons, i.e. those with the biggest mass, are the most severely affected; namely, the proximal muscle groups (e.g. trunk, neck, and hip muscles).

There is a spectrum of clinical severity in this disorder, but all types can be confirmed by testing for SMN1 gene deletion. In type 1 (Werdnig–Hoffmann disease), the most severe form of the disease which presents in infancy, there are the characteristic features of anterior horn cell disease, including tongue fasciculations, which are almost pathognomic. Children are hypotonic and areflexic and develop early respiratory symptoms. Death is usually within a matter of weeks or months.

At the same location as SMN1 is a centromeric gene, SMN2 , which also codes for SMN protein. Most people have two copies of SMN2 . In a child with SMA, the presence of normal copies of SMN2 can partially compensate for the absence of normal SMN1 function. If a child with SMA has only one or no copies of SMN2 , their clinical course will be more severe.

Electromyography (EMG) and muscle biopsy findings are non-specific and, if there is clinical suspicion of spinal muscular atrophy, molecular genetic studies should be requested.

Spinal muscular atrophy with respiratory distress

Spinal muscular atrophy with respiratory distress (SMARD) may present between 6 weeks and 6 months of life, with respiratory failure secondary to diaphragm weakness. The diagnostic test for this disorder is to look for mutations in the IGHMBP2 gene. The condition follows an autosomal recessive inheritance. Diaphragm eventration tends to be associated with this disorder.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here